Synthetic cannabinoid dependence, early full remission

Description

After a diagnosis of synthetic cannabinoid dependence, and often following a treatment episode or other intervention (including self-help intervention), the individual has been abstinent from synthetic cannabinoid use during a period lasting between 1 and 12 months.

Index terms

Synthetic cannabinoid dependence, early full remission

Excludes

6C42.0 – Episode of harmful use of synthetic cannabinoids
6C42.1 – Harmful pattern of use of synthetic cannabinoids

Exclusions from above levels

6C41 – Disorders due to use of cannabis
QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Sibling codes

6C42.20 – Synthetic cannabinoid dependence, current use
6C42.22 – Synthetic cannabinoid dependence, sustained partial remission
6C42.23 – Synthetic cannabinoid dependence, sustained full remission
6C42.2Y – Other specified synthetic cannabinoid dependence
6C42.2Z – Synthetic cannabinoid dependence, unspecified

Foundation entity

Synthetic cannabinoid dependence, early full remission – http://id.who.int/icd/entity/2648920

Allowed postcoordination axes

Part of: 6C42.2: Synthetic cannabinoid dependence › 6C42: Disorders due to use of synthetic cannabinoids › 06: Mental, behavioural or neurodevelopmental disorders